Biotech company Trialjectory is creating a new technology service to match cancer patients with clinical trials. The company has raised $2.7 million to complete this goal. “One of the top obstacles that oncologists face today is the lack of clinical trial access for patients, which is due to the availability of more treatment options overall,” said Tzvia Bader, Trialjectory CEO and co-founder. At Yourway, we offer direct-to-patient services to facilitate decentralized clinical trials.